Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial, pt. 2

Summary: Prof. Gil Wolfe discusses who might and might not be good candidates for thymectomy for non-thymomatous myasthenia gravis in the second part of his interview with Dr. Ted Burns. Read the full study in Lancet Neurology: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(18)30392-2/fulltext. The study was also covered in Neurology Today, which you can read here: https://journals.lww.com/neurotodayonline/pages/articleviewer.aspx?year=2019&issue=03070&article=00004&type=FullText.